Premium
The Wiskott‐Aldrich syndrome protein regulates CTL cytotoxicity and is required for efficient killing of B cell lymphoma targets
Author(s) -
De Meester Julie,
Calvez Ronan,
Valitutti Salvatore,
Dupré Loïc
Publication year - 2010
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0410197
Subject(s) - ctl* , biology , cytotoxic t cell , lytic cycle , immunology , cancer research , cd8 , b cell , virology , microbiology and biotechnology , immune system , virus , antibody , genetics , in vitro
CD8 + T cells from Wiskott‐Aldrich syndrome patients fail to efficiently kill B cell lymphoma cells in vitro.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom